Meta-Analysis
Copyright ©The Author(s) 2021.
World J Gastrointest Oncol. Sep 15, 2021; 13(9): 1196-1209
Published online Sep 15, 2021. doi: 10.4251/wjgo.v13.i9.1196
Table 1 Characteristics of all studies
Ref.
Race
Sample size
Tumor stage
Surgery
Chemotherapy
Radiotherapy (Gy)
nCT
nCRT
nCT
nCRT
Huang et al[8], 2016Asian102II–IIIAR, LAR, etc.AR, LAR, etc.mFOLFOX6mFOLFOX650
Deng et al[9], 2016, Deng et al[10], 2019Asian475II–IIITMETMEmFOLFOX6mFOLFOX6/FOLFOX646.0–50.4
Sun et al[11], 2019Asian220II–IIITMETMEmFOLFOX65-FU; mFOLFOX646.0–50.4
Fan et al[13], 2015Asian184II–IIITMETMEXELOXXELOX46
Qin et al[12], 2016Asian318II–IIINANA5-FU, FOLFOX5-FU, FOLFOX50
Zhang et al[15], 2017Asian142LARCNANAmFOLFOXIRImFOLFOXIRINA
Sato et al[16], 2019Asian26LARCTME; LLNDTME; LLNDS1 + oxaliplatin5FU-based4045
Diaz et al[17], 2019NA46II/IIITMETMEmFOLFOX6; CAPOX; FLOXFluorouracil/oral capecitabine50.0 or 50.4
Ikematsu et al[18], 2014NA77III - IVISRISRmFOLFOX65-fluorouracil45
Sun et al[19], 2016Asian22094II–IIINANANANANA
Cassidy et al[20], 2016NA21707IIINANANANANA
Kim et al[21], 2015Asian86IVTMETMEFOLFOX4; FOLFIRI; 5-FU/LV, + capecitabine5-FU/LV or capecitabine45.0-50.4
Matsumoto et al[23], 2015Asian124II–IIILAR, APR/ASR, Hartmann, ISRLAR, APR/ASR, Hartmann, ISRFOLFOX; IRIS; FOLFIRIFOLFOX; IRIS; FOLFIRINA
Sakuyama et al[24], 2016Asian88Ⅰ-ⅣISR, etc.ISR, etc.FOLFOXFOLFOX45
Sada et al[25], 2018Asian11839II–IIINANANANA40-55
Suárez et al[26], 2011NA25AR, APR, HartmannAR, APR, Hartmann5-FU + oxaliplatin-basedfluoropyrimidine-based50.40
Rouanet et al[14], 2017NA29LARCTME, etc.TME, etc.FOLFIRINOXFOLFIRINOX50
Okuyama et al[22], 2018Asian55II–IIILAR, APRLAR, APRoxaliplatin-based5-FU-based45
He et al[27], 2020Asian3233II–IIITMETMEFOLFOX; CAPOXFOLFOX; CAPOX50